The main aim is to explore the characteristics of behavior based on the discriminative stimulus effects of drug mixtures. Existing, well-developed methods for studying discriminate stimulus effects on drugs focus almost exclusively on single drugs, whereas the abuse of mixtures of more than one drug at a time is a widespread health problem. A secondary aim is to clarify understanding of the effect of single drugs with multiple effects; such drugs may be discriminated as a stimulus complex consisting of two or more elements and studies will clarify ways in which such a compound, interoceptive stimuli are processed. In the work proposed, the effects of behavioral and pharmacological variables on the characteristics of discriminations based on drug mixtures will be examined in greater depth than was the case previously. All experiments will utilize two-bar, operant conditioning procedures in rats and in some cases novel forms of these methods will be evaluated. While including comparisons of the discriminative effects of abused mixtures of amphetamine plus pentobarbital with those of non-abused mixtures of nicotine plus midazolam, the project will determine the influence of different training procedures and of different previous behavioural and pharmacological histories. Behavioural mechanisms that may account for some interactions between drugs in mixtures will be examined, based upon effects that associative learning theorists call blocking and overshadowing. The effects of antagonists, and the roles of the doses and dose-ratios of drugs used for training will be determined. The specificity of discriminative stimuli trained in different ways will be evaluated in generalization tests with pharmacologically similar drugs and drug mixtures, and with compounds from other pharmacological classes. The work will suggest ways in which environmental factors may modify responses to drug mixtures and thus influence the individual potential for engaging in addictive behaviors.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA005543-06
Application #
3211945
Study Section
Drug Abuse Clinical and Behavioral Research Review Committee (DACB)
Project Start
1988-09-01
Project End
1994-08-31
Budget Start
1993-09-01
Budget End
1994-08-31
Support Year
6
Fiscal Year
1993
Total Cost
Indirect Cost
Name
University of London Institute of Psychiatry
Department
Type
DUNS #
City
London
State
Country
United Kingdom
Zip Code
Stolerman, I P; Mariathasan, E A (2003) Nicotine trace discrimination in rats with midazolam as a mediating stimulus. Behav Pharmacol 14:55-66
Stolerman, I P; Childs, E; Hahn, B et al. (2002) Drug trace discrimination with nicotine and morphine in rats. Behav Pharmacol 13:49-58
Stolerman, I P; Olufsen, K S (2000) Influence of training history on ethanol discrimination in rats. Behav Pharmacol 11:603-12
Stolerman, I P; Mariathasan, E A; White, J A (1999) Influencing the specificity of drug mixture discriminations by varying the training procedure. Behav Pharmacol 10:657-64
Mariathasan, E A; Stolerman, I P (1994) Functional relationships, previous history and the discrimination of a drug mixture in rats. Drug Alcohol Depend 35:117-25
Mariathasan, E A; Stolerman, I P (1992) Drug discrimination studies in rats with caffeine and phenylpropanolamine administered separately and as mixtures. Psychopharmacology (Berl) 109:99-106
Marston, H M; Garcha, H S; Robbins, T W et al. (1992) Drug discrimination learning in rats with excitotoxic lesions of nucleus basalis and ventral globus pallidus. Behav Brain Res 51:93-102
Stolerman, I P; Mariathasan, E A; Garcha, H S (1991) Discriminative stimulus effects of drug mixtures in rats. NIDA Res Monogr :277-306
Stolerman, I P; Mariathasan, E A (1990) Discrimination of an amphetamine-pentobarbitone mixture by rats in an AND-OR paradigm. Psychopharmacology (Berl) 102:557-60